Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ADMA Biologics Inc (ADMA) vs Direxion Daily CSI China Internet Bull 2X Shares (CWEB) Price & Performance

ADMA Biologics Inc
Direxion Daily CSI China Internet Bull 2X Shares

Price performance

Price movement over the last 24 hours

Key statistics

ADMA Biologics Inc vs Direxion Daily CSI China Internet Bull 2X Shares — how do they compare? ADMA Biologics Inc trades at $9.25 (market cap $2.13B), while Direxion Daily CSI China Internet Bull 2X Shares trades at $22.05. Which is the better fit depends on your goals.

ADMACWEB
Market Cap
$2.13B
Sector
HealthLeveraged / Inverse
52-Week High
$20.38$60.13
52-Week Low
$7.60$17.70
Enterprise Value
$2.20B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ADMA Biologics Inc

ADMA trades at $9.16, up 2.35% today, with a bullish technical signal from moving averages and oscillators. The company reported strong profitability with a 32.43% net income margin and 43.3% ROE for 2025, though recent EPS results were mixed. Analyst consensus is strongly bullish with an $19.00 price target, but multiple class action lawsuits filed in July 2026 alleging securities fraud create significant near-term uncertainty.

The stock offers substantial upside to analyst targets if legal challenges are resolved favorably, supported by robust fundamentals and projected cash flow growth. Primary risks include the outcome of ongoing litigation and potential reputational damage. Investors should weigh strong financial performance against elevated legal and sentiment risks before establishing a position.

Direxion Daily CSI China Internet Bull 2X Shares

CWEB stock is trading at $20.66, up 5.09% with a bullish technical signal supported by moving averages. The stock shows mixed momentum with RSI indicators suggesting both overbought and neutral conditions. Recent corporate action includes a $0.09 dividend scheduled for June 2026. Trading activity indicates strong interest with the current price near pivot point resistance levels.

The stock's technical strength contrasts with limited fundamental data availability. Investment appeal hinges on upcoming financial disclosures to validate current market positioning. Key risks include reliance on technical momentum without clear fundamental support and market volatility affecting short-term price action.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.

Read more on ADMA

About Direxion Daily CSI China Internet Bull 2X Shares

CWEB is a leveraged ETF that seeks to provide two times (2x) the daily performance of the CSI China Internet Index. It offers magnified exposure to top Chinese internet companies listed on US and Hong Kong exchanges.

Read more on CWEB